Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stelara
Pharma
J&J ushers in new 340B rebate policy for Stelara, Xarelto
The new rebate model would require eligible hospitals to submit rebate claims after paying full price for the drugs, as opposed to upfront discounts.
Zoey Becker
Aug 26, 2024 11:23am
Samsung Biologics' 37% sales surge propelled by biosimilars
Jul 24, 2024 10:56am
Subcutaneous version of J&J's Tremfya excels in Crohn's trial
Jun 20, 2024 11:12am
Colorado drug review board finds J&J's Stelara unaffordable
Jun 11, 2024 9:05am
Lilly pads case for mirikizumab in its next potential indication
May 21, 2024 9:20am
AbbVie's Skyrizi continues booming growth trajectory
Apr 26, 2024 12:06pm
